Equity · Technology
AXT, Inc. (AXTI) perpetual futures
AXTI perpetual futures on 18 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade AXTIUSDT.
AXT, Inc. designs, develops, and distributes compound and single-element semiconductor substrates, including indium phosphide, gallium arsenide, and germanium, for applications in 5G, fiber optics, LEDs, and solar cells.
Price chart
Interactive TradingView chart
TradingView symbol NASDAQ:AXTI
Loads TradingView's third-party widget (about 1 MB) on demand.
Trading data
Perpetual market activity
18/18 live markets
Trading data
Perpetual market activity
Spot performance
Venue matrix
18 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
| Trade | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Binance | Trade | AXTI/USDT | Trading | $39.78 | 0.0% APR 0.000% every 8h | +2.5 bps | $286.7K | $41.2M | $4.8M | USDT | - | |
 OKX | Trade | AXTI/USDT | Trading | $39.77 | 0.0% APR 0.000% every 8h | +2.5 bps | $482.2K | $14.8M | $2.4M | USDT | 20x | |
 Gate.io | Trade | AXTI/USDT | Trading | $39.76 | 0.0% APR 0.000% every 8h | +17.7 bps | $268.2K | $3.8M | $909.4K | USDT | 50x | |
 Bitget | Trade | AXTI/USDT | Trading | $39.75 | 0.0% APR 0.000% every 8h | +7.6 bps | $732.9K | $3.2M | $665.8K | USDT | 20x | |
 KuCoin | Trade | AXTI/USDT | Trading | $39.77 | 0.0% APR 0.000% every 8h | +20.3 bps | $28.3K | $1.7M | $255.7K | USDT | 20x | |
 MEXC | Trade | AXTI/USDT | Trading | $39.77 | 0.0% APR 0.000% every 8h | +2.5 bps | $528.2K | $1.4M | $74.2K | USDT | 50x | |
 Bybit | Trade | AXTI/USDT | Trading | $39.78 | 0.0% APR 0.000% every 8h | +15.2 bps | $17.6K | $787K | $803K | USDT | 25x | |
 GRVT | Trade | AXTI/USDT | Trading | $39.76 | 0.0% APR 0.000% every 8h | +22.8 bps | $66.2K | $294.9K | $811.2 | USDT | - | |
 HTX | Trade | AXTI/USDT | Trading | $39.48 | 0.0% APR 0.000% every 8h | +35.5 bps | $16.4M | $167.4K | $12.6K | USDT | - | |
 Aster | Trade | AXTIUSDT | Trading | $39.72 | 0.0% APR 0.000% every 8h | +15.2 bps | $79K | $36.5K | $19.2K | USDT | - | |
 Extended | Trade | AXTI/USD | Trading | $39.74 | 0.0% APR 0.000% every 1h | +5.8 bps | - | $5.7K | $2.8K | USD | 10x | |
 Crypto.com Exchange | Trade | AXTI/USD | Trading | $39.65 | +81.2% APR +0.00927% every 1h | +15.2 bps | $5.1K | $3.5K | $1.5K | USD | 50x | |
 Aevo | Trade | AXTI/USDC | Trading | $39.74 | +11.4% APR +0.00130% every 1h | +37.5 bps | $186K | $0 | $0 | USDC | 10x | |
 XT.com | Trade | AXTI/USDT | Trading | $39.75 | 0.0% APR 0.000% every 8h | +5.1 bps | $20.6K | $14.4M | - | USDT | 20x | |
 BingX | Trade | AXTI-USDT | Trading | $39.80 | +5.5% APR +0.00500% every 8h | +7.7 bps | $969.8K15 min | $1.7M | - | USDT | - | |
 LBank | Trade | AXTI/USDT | Trading | $39.77 | 0.0% APR 0.000% every 8h | +5.1 bps | $1.9M | $817.3K | - | USDT | 50x | |
 Deepcoin | Trade | AXTI/USDT | Trading | $39.78 | +21.6% APR +0.020% every 8h | +5.1 bps | $262.5K | $25.7M⚠ | $3K | USDT | 25x | |
 Bitunix | Trade | AXTI/USDT | Trading | $39.80 | +2.2% APR +0.00200% every 8h | +7.6 bps | $857.2K | $1.4M⚠ | $36.2K | USDT | 20x |
Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.
Tokenized wrappers of the real stock, tradable on-chain and on crypto exchanges around the clock. Premium/discount compares the token price to our stock reference price. Data: CoinMarketCap · Robinhood · DexScreener · GeckoTerminal.
| Product | Price | Premium vs stock | 24h Vol. | Market Cap | Chains |
|---|---|---|---|---|---|
| AXTIBbStocks | $39.17 | -0.78% | $5.1M | $2.4M | BNB Smart Chain (BEP20) |
| rAXTITokenized | $42.80 | +8.40% | $83k | $284k | Arbitrum |
| AXTIRobinhood | – | – | – | $3k | Robinhood Chain |
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kBroad liquidity · 15 of 18 venues absorb $10k · Typical cost: +10.2 bps – +26.6 bps
Too thin: KuCoin, Crypto.com Exchange
No fresh book data: Extended
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
AXTITightest spread
AXTIHighest volume
AXTIFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketNext catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
Latest annualAnalysts
Price targets in USD| Consensus rating | Buy |
|---|---|
| Average 12-month price target | $101.67 |
| 12-month target range (low – high) | $90 – $125 |
| Ratings in the provider's consensus | 11 |
Price targets as of 2026-11-13
Analyst rating history
Ratings| Month | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| Nov 2026 | 2 | 3 | 1 | 0 | 0 |
| Oct 2026 | 1 | 3 | 1 | 0 | 0 |
| Sep 2026 | 1 | 3 | 1 | 0 | 0 |
| Aug 2026 | 1 | 3 | 2 | 0 | 0 |
| Jul 2026 | 1 | 3 | 2 | 0 | 0 |
| Jun 2026 | 0 | 3 | 2 | 0 | 0 |
| May 2026 | 0 | 3 | 2 | 0 | 0 |
| Apr 2026 | 0 | 3 | 2 | 0 | 0 |
| Mar 2026 | 0 | 3 | 2 | 0 | 0 |
| Feb 2026 | 0 | 3 | 2 | 0 | 0 |
| Jan 2026 | 1 | 4 | 2 | 0 | 0 |
| Dec 2025 | 1 | 4 | 0 | 0 | 0 |
Ownership
Institutional · 2026-Q3Reference market activity
AXTI-PERPPrice performance
11Insider activity
FY2026 Q4Insider transactions
25AXT CEO Morris S. Young received a grant (Code A) of 23,350 common shares at $0.00 on Oct 27, 2026, leaving him with 2,171,683 shares owned.
AXT CFO Gary L. Fischer received an award of 8,524 common shares at $0.00 on Oct 27, 2026, after which he held 199,802 shares.
Director Leonard J. LeBlanc sold 2,500 common shares of AXT in two open-market transactions (June 10 and Aug 7, 2026) at prices between $88.315 and $89.59.
Director Leonard J LeBlanc sold 4,000 common shares of AXT, Inc. on August 17, 2026, at $96.07 each, reducing his holdings to 113,129 shares.
This is an initial ownership statement (Form 3) for director Duh Jia-bin at AXT, Inc., reporting existing holdings of 2,500 and 667 shares of common stock, with no shares acquired or sold.
This Form 3 filing discloses director Tracy Liu's initial ownership at AXT, Inc.: no new shares were acquired, but existing holdings of 2,500 and 726 shares of common stock are reported.
Director Jesse Chen sold 6,172 shares of AXT common stock on the open market at $115.2437 per share, leaving 50,275 shares owned afterward.
Director David C Chang sold 8,333 shares of AXT common stock at $111.1715 on 2026-06-15, leaving 65,165 shares owned afterward.
AXT CEO Morris S. Young gifted 1,200 shares of common stock on 2026-06-12, leaving him with 2,148,333 shares owned after the transaction.
Director Jesse Chen sold 22,000 AXT shares on the open market over two trades (June 11-12, 2026) at prices between $88.55 and $95.77, leaving 56,447 shares owned afterward.
Director Jesse Chen sold 16,500 shares of AXT common stock across three transactions on Jun 8-10, 2026, at prices between $86.73 and $94.00, leaving 78,447 shares owned afterward.
Director Jesse Chen sold a total of 10,133 common shares across two transactions at prices between $108.28 and $111.36, and received an award of 754 shares at $105.99.
Director Leonard J. LeBlanc was awarded 754 shares of AXT common stock at $105.99 per share, bringing his total holdings to 119,629 shares.
Director David C. Chang received a grant of 754 shares of AXT common stock, bringing his total holdings to 73,498 shares.
AXT CEO Morris S. Young exercised options on 85,703 common shares at $5.21 and sold 73,897 shares at $112.3907.
Filings
49 · Latest SEC filingsAXT CFO Gary L. Fischer received an award of 8,524 common shares at $0.00 on Oct 27, 2026, after which he held 199,802 shares.
AXT CEO Morris S. Young received a grant (Code A) of 23,350 common shares at $0.00 on Oct 27, 2026, leaving him with 2,171,683 shares owned.
Director Leonard J. LeBlanc sold 2,500 common shares of AXT in two open-market transactions (June 10 and Aug 7, 2026) at prices between $88.315 and $89.59.
Director Leonard J LeBlanc sold 4,000 common shares of AXT, Inc. on August 17, 2026, at $96.07 each, reducing his holdings to 113,129 shares.
This is an initial ownership statement (Form 3) for director Duh Jia-bin at AXT, Inc., reporting existing holdings of 2,500 and 667 shares of common stock, with no shares acquired or sold.
This Form 3 filing discloses director Tracy Liu's initial ownership at AXT, Inc.: no new shares were acquired, but existing holdings of 2,500 and 726 shares of common stock are reported.
Director Jesse Chen sold 6,172 shares of AXT common stock on the open market at $115.2437 per share, leaving 50,275 shares owned afterward.
Director David C Chang sold 8,333 shares of AXT common stock at $111.1715 on 2026-06-15, leaving 65,165 shares owned afterward.
AXT CEO Morris S. Young gifted 1,200 shares of common stock on 2026-06-12, leaving him with 2,148,333 shares owned after the transaction.
Director Jesse Chen sold 22,000 AXT shares on the open market over two trades (June 11-12, 2026) at prices between $88.55 and $95.77, leaving 56,447 shares owned afterward.
Director Jesse Chen sold 16,500 shares of AXT common stock across three transactions on Jun 8-10, 2026, at prices between $86.73 and $94.00, leaving 78,447 shares owned afterward.
Director Jesse Chen sold a total of 10,133 common shares across two transactions at prices between $108.28 and $111.36, and received an award of 754 shares at $105.99.
Director Leonard J. LeBlanc was awarded 754 shares of AXT common stock at $105.99 per share, bringing his total holdings to 119,629 shares.
Director David C. Chang received a grant of 754 shares of AXT common stock, bringing his total holdings to 73,498 shares.
AXT CEO Morris S. Young exercised options on 85,703 common shares at $5.21 and sold 73,897 shares at $112.3907.
Morris S. Young, CEO and director of AXT, Inc., gifted a total of 14,000 shares of common stock in two separate transactions on 2026-05-01. No shares were purchased or sold; these were gifts, not open-market trades.
Transcripts
Earnings callsFY2026 Q12026-04-30
Earnings calls
AI summary
positiveAXT achieved Q1 2026 revenue of $26.9 million with substantial gross margin improvement to 29.9% non-GAAP, driven by higher Indium Phosphide volumes and favorable product mix. The company expects sequential Q2 revenue growth with $34 million in confirmed revenue visibility and projects non-GAAP net income of $0.06 to $0.08 per share. Management is executing a multi-year capacity expansion plan to double Indium Phosphide production annually through 2027, with backlog reaching record levels fueled by AI infrastructure buildout globally.
Key takeaways
- Q1 revenue of $26.9 million vs $23.0 million in Q4 2025; Indium Phosphide at $13.6 million representing over 50% of total revenue
- Non-GAAP gross margin improved to 29.9% in Q1 from 21.5% in Q4 2025, driven by volume and Indium Phosphide mix
- Indium Phosphide backlog reached record high of over $100 million with Q2 expected to be largest Indium Phosphide quarter in company history
- Plan to double Indium Phosphide capacity by end of 2026 to $35 million quarterly run rate, then double again in 2027 to $65-70 million quarterly capacity
- China Indium Phosphide revenue more than doubled in Q1 and expected to double again in Q2, with China representing approximately 30% of global Indium Phosphide demand in Q2
Financial highlights
- Q1 2026 revenue: $26.9 million vs Q4 2025: $23.0 million vs Q1 2025: $19.4 million
- Non-GAAP gross margin Q1: 29.9% vs Q4: 21.5% vs Q1 2025: negative 6.1%
- Non-GAAP net loss Q1: $585,000 or $0.01 per share vs Q4: $2.3 million or $0.05 per share
- Cash and investments: $123 million as of March 31, 2026; Indium Phosphide backlog: over $100 million
Guidance
- Q2 2026: approximately $34 million revenue with confirmed permit coverage, potential for significant upside if additional export permits received
- Q2 2026: non-GAAP net income of $0.06 to $0.08 per share; GAAP net income of $0.05 to $0.07 per share
- Q2 2026: non-GAAP operating expenses approximately $9.3 million; GAAP operating expenses approximately $10 million
- Expected to achieve profitability on both GAAP and non-GAAP basis in Q2 2026; gross margin expected to exceed 30% threshold
Q&A themes
- Customers discussing long-term supply agreements with AXT; hyperscalers encouraging direct suppliers to sign agreements with AXT to secure capacity
- Export permits remain critical variable to revenue realization; permits for U.S. customers shipping from other regions are being approved; Ministry of Commerce in China contacted company requesting additional data on U.S. permit applications, indicating continued possibility for U.S. permits
- Pricing increases being implemented for Indium Phosphide substrates due to raw material cost increases, particularly Indium; company pursuing global pricing standardization across regions
- 6-inch Indium Phosphide product development progressing with customers; 4-inch demand very strong with transition accelerating; 3-inch still majority but declining relative to larger wafer sizes
Risks
- Export permit timing and approval remain unpredictable and not under company control; cannot guarantee timing or success of obtaining permits for any customer or individual order
- Geopolitical complexity and dynamic environment surrounding China operations and AI infrastructure market could impact business
- Company acknowledges manufacturing at scale for Indium Phosphide is difficult; need for 10x capacity growth against ability to realistically achieve it presents execution risk
FY2025 Q42026-02-19
Earnings calls
AI summary
positiveAXT posted Q4 2025 revenue of $23.0 million with non-GAAP gross margin of 21.5% and non-GAAP net loss of $0.06 per share. The company raised $93.9 million in December 2025, strengthening its balance sheet to $128.4 million in cash and investments. Management expects sequential revenue growth in Q1 2026 to approximately $26 million, supported by a record indium phosphide backlog exceeding $60 million and 25% capacity expansion already completed, with plans to double capacity by year-end 2026.
Key takeaways
- Indium phosphide backlog reached record $60+ million, driven by AI infrastructure and optical transceiver demand across U.S. hyperscalers and China data centers
- Q1 2026 revenue guidance of ~$26 million in committed permits with potential for significant upside if additional export permits are received
- Capacity increased 25% in Q4 2025; company plans to double capacity from Q4 2025 levels by end of 2026 at approximately $30 million CapEx, with potential for additional doubling in 2027 requiring $100-150 million
- Export permits from China's Ministry of Commerce (MOFCOM) identified as single most significant growth gating factor; some permits denied with resubmission instructions
- Expanding customer base including new Tier 1 optical and laser customers; customers forecasting demand growth 3-5x over next 4-5 years with visibility beyond 2030
Financial highlights
- Q4 2025 revenue: $23.0 million (Q3: $28.0 million, Q4 2024: $25.1 million)
- Q4 2025 non-GAAP gross margin: 21.5% (Q3: 22.6%, Q4 2024: 18.0%)
- Q4 2025 non-GAAP net loss: $2.6 million or $0.06 per share (Q3: $1.2 million or $0.02, Q4 2024: $4.2 million or $0.10)
- Cash, cash equivalents and investments increased to $128.4 million from $31.2 million, primarily from $93.9 million public offering proceeds
Guidance
- Q1 2026 revenue guidance: approximately $26 million with high confidence for permits already obtained; potential for significant upside with additional permits
- Q1 2026 non-GAAP net loss guidance: $0.02 to $0.04 per share; GAAP net loss: $0.04 to $0.06 per share
- Q1 2026 operating expenses expected at approximately $9.0 million
- Indium phosphide revenue expected to grow more than 60% in Q1 2026 compared to Q4 2025, primarily China data center growth
Q&A themes
- Export permit process lacks transparency with highly variable timing; some permits denied with instructions to resubmit with additional information; MOFCOM (Ministry of Commerce) reviewing resubmitted denials
- Customers placing longer-term orders with forecasts extending beyond 2030; demand growing weekly as customers report upsizing requirements across 3-inch, 4-inch, and 6-inch wafer sizes
- Company building inventory ahead of permits ('staging' finished goods) rather than waiting for permits; manufacturing to backlog and forecast
- Significant capacity expansion ongoing including vertical integration through subsidiaries JinMei (indium refining) and others in supply chain; 6-inch indium phosphide expansion underway but still in development stage with initially lower margins
Risks
- Export permits from China remain unpredictable and non-transparent; timing and approval rates cannot be controlled or reliably forecast, creating significant near-term revenue volatility despite strong underlying demand
- Geopolitical environment is dynamic and could impact future permit issuance; denials have been received requiring resubmission with unknown approval timeline
- Company building substantial inventory ahead of permits and capacity expansion; if demand does not materialize or permits are delayed further, inventory buildup could pressure margins and cash flow
FY2025 Q32025-10-30
Earnings calls
AI summary
positiveAXT achieved strong sequential growth in Q3 2025 with revenue of $28.0M (up 56% QoQ, 18% YoY), driven primarily by indium phosphide demand for data center and optical connectivity applications. The company obtained significant export permits enabling shipments and built a record $49M indium phosphide backlog. Non-GAAP gross margin improved to 22.4% from 8.2% in Q2, though the company remains unprofitable due to export permit timing constraints.
Key takeaways
- Indium phosphide revenue reached $13.1M in Q3, the highest since 2022, with backlog now exceeding $49M, more than double the prior quarter
- Export permits remain the primary gating factor; current processing time is approximately 60 business days (3 months), with Golden Week in October expected to add ~1 week delay in Q4
- Company estimates current indium phosphide capacity at ~$20M per quarter and can increase 25% within 3 months or double capacity within 9 months for $10-15M CapEx investment
- Engaging with new Tier 1 customers including optical transceiver makers, GPU/CPU makers, and hardware integrators for the first time in many years
- Asia Pacific represents 87% of revenue; U.S. hyperscaler CapEx spending on AI infrastructure is primary driver for EML and silicon photonics optical transceivers
Financial highlights
- Q3 2025 revenue: $28.0M (Q2: $18.0M, Q3 2024: $23.6M)
- Non-GAAP gross margin: 22.4% (Q2: 8.2%, Q3 2024: 24.3%)
- Non-GAAP operating loss: $384K (Q2: $6.1M loss, Q3 2024: $2.6M loss)
- Non-GAAP net loss: $1.2M or $0.03 per share (Q2: $6.4M or $0.15 per share)
Guidance
- Q4 2025 revenue guidance: $27M-$30M, with ~$20M having high confidence (either permits obtained or no permit required) and incremental $7M-$10M potential subject to permit timing
- Q4 non-GAAP net loss guidance: $0.01-$0.03 per share; GAAP net loss: $0.03-$0.05 per share
- Operating expenses expected to increase to ~$9M in Q4 due to end-of-year adjustments and normalization
- Germanium substrates expected flat in Q4 due to poor gross margin potential; raw materials expected to remain stable and profitable
Q&A themes
- Export permit dynamics: Permits last 6 months with up to 12 line items (separate POs require separate permits); customers placing orders in confidence based on high historical resubmission rates
- Customer behavior shift: Longer-term orders and greater visibility as customers adapt to ~3-month permit processing times; customers building inventory levels for multiyear cycle, not one-time build
- Capacity and growth potential: Current $20M quarterly capacity can scale 25% in 3 months without capex; doubling capacity requires 9 months and $10-15M; potential CPO scale-up demand described as 'tsunami' (5-10x growth) by end customers
- New customer engagements: Direct relationships now with GPU/CPU makers, hardware integrators, and pluggable module makers previously inaccessible; customers citing superior EPD (electron propagation defect) quality driving higher device yields
Risks
- Export permit timing and approval uncertainty remains primary constraint on Q4-Q1 revenue realization; geopolitical dynamics and China Ministry of Commerce processing timelines not fully controllable
- Gross margin recovery dependent on achieving higher volume utilization and product mix; germanium substrate business weak with margin pressure; inventory levels remain elevated at $77.7M despite $2.4M reduction
- One-time customer inventory build-out risk though management characterizes demand as multiyear cycle; competitive capacity announcements from Japanese competitors may pressure future market share
FY2025 Q22025-07-31
Earnings calls
AI summary
mixedAXT's Q2 2025 revenue declined 35% year-over-year to $18.0 million due to slower-than-expected Chinese export permits for gallium arsenide and indium phosphide, which the company estimates caused approximately half the revenue shortfall. However, the company achieved meaningful gross margin improvement to 8.2% from negative 6.1% in Q1, driven by manufacturing efficiency gains. Despite near-term headwinds from geopolitical restrictions, AXT is benefiting from strong AI-driven demand for indium phosphide in China's data center market and maintains a $10 million+ order backlog.
Key takeaways
- Q2 revenue $18.0M (-35% YoY); gross margin improved to 8.2% from Q1's -6.1%, reflecting manufacturing efficiency gains
- Export permit delays caused approximately 50% of Q2 revenue shortfall; permits for gallium arsenide began accelerating in July with improved cadence expected
- Received first indium phosphide export permit in June and shipped ~$700K; expecting growth of 30%+ for total indium phosphide revenue in Q3
- Strong indium phosphide demand within China for AI/data center connectivity and PON applications; gallium arsenide wireless business growing despite sluggish overall China demand
- $10M+ backlog for gallium arsenide and indium phosphide with >50% being indium phosphide; company estimates 4-6 week production cycle
Financial highlights
- Q2 2025 revenue: $18.0M (Q1: $19.4M, Q2 2024: $27.9M); product breakdown: indium phosphide $3.6M, gallium arsenide $6.2M, germanium $1.5M, joint ventures $6.7M
- Non-GAAP gross margin Q2: 8.2% (Q1: -6.1%, Q2 2024: 27.6%); non-GAAP operating loss $6.1M vs. $9.6M in Q1
- Non-GAAP net loss Q2: $6.4M or $0.15/share (Q1: $8.2M or $0.19/share, Q2 2024: $0.8M or $0.02/share)
- Cash and investments decreased $3.1M to $35.1M; net inventory down $300K to $80.1M; weighted average shares outstanding 43.7M
Guidance
- Q3 2025 revenue guidance: $19.0M to $21.0M, expecting indium phosphide revenue growth of 30%+ driven by PON, data center connectivity and sensors
- Q3 expected gross margin improvement to low-mid to mid-teens range; non-GAAP net loss $0.11-$0.13/share, GAAP net loss $0.13-$0.15/share
- Germanium revenue expected to decline in Q3; raw material business approximately flat Q3 vs. Q2
- Guidance includes only revenue for which company currently has permits; potential upside if additional permits issued in Q3
Q&A themes
- Export permit delays and competitive risk: Company believes market growing too fast for 2 suppliers; maintains 40-50% global indium phosphide market share with quality/EPD advantages; receiving daily new orders despite permit delays
- AI-driven demand acceleration: Higher-speed transceivers (800G to 3.2T) require lower EPD material; larger device sizes increase indium phosphide acreage per unit, creating dual growth drivers
- Permit process normalization: Gallium arsenide permit acceleration in July suggests backlog clearing; delays appear industry-wide and potentially tied to rare earth restrictions as negotiating tool; expecting return to normal cadence soon
- Inventory building potential: Customers signaling intent to place larger orders and build inventory once permits resume normal flow; company not yet at stage of large deliveries to support pre-building
Risks
- Geopolitical export restrictions on gallium arsenide (August 2023) and indium phosphide (February 2025) create near-term revenue headwinds; permit delays have already impacted Q2 results and create uncertainty for Q3 execution
- Customer concentration and potential share loss: Top 5 customers represent 30.9% of revenue; prolonged permit delays could cause customers to source from competitors, though company believes market demand exceeds 2-player capacity
- Germanium business margin pressure and permit challenges: Sharp rise in raw material pricing has severely constrained gross margins; export permits for germanium outside China difficult to obtain, with revenue expected to remain at lower levels through H2 2025
Company news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
Company data
Company intelligence
Updated: Nov 13, 2026, 01:01 PM UTC
Company data
Company intelligence
Company profile
- Sector
- Technology
- Industry
- Semiconductors
- Chief executive
- Morris S. Young
- Employees
- 1,541
- IPO date
- May 21, 1998
- Country
- US
- Exchange
- NASDAQ Global Select
Rating factors
- Return on equityi
- 2/5
- Return on assetsi
- 2/5
- Debt to equityi
- 3/5
- Price to earningsi
- 1/5
- Price to booki
- 2/5
Company press releases
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| VTI | 0.01% | 2M |
| IWM | 0.12% | 1.7M |
| PSI | 2.72% | 1.1M |
| FSSNX | 0.14% | 759.2K |
| VB | 0.02% | 714.5K |
| VXF | 0.04% | 695.3K |
| IWO | 0.24% | 586.5K |
| PTF | 5% | 422.3K |
| VBK | 0.05% | 409.3K |
| VTWO | 0.12% | 359K |
| FSMAX | 0.05% | 279.5K |
| VEXPX | 0.05% | 158.6K |
Analyst track record
How the analysts covering AXTI have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 32 | 74 |
| Analysts | 6 | 6 |
| Buy / hold / sell | 24 / 8 / 0 | 66 / 8 / 0 |
| Upgrades / downgrades / initiations | 1 / 2 / 0 | 3 / 2 / 0 |
| Price targets hit / missed | 8 / 17 (32%) | 41 / 17 (71%) |
| Avg. return after a rating (TipRanks) | -6.5% | +496.0% |
| Best / worst call | +141.9% / -65.2% | > +1,000% / -65.2% |
After buy calls on this stock: median 21-day move +18.6% vs S&P 500 +17.9% (n = 64)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Richard ShannonCraig-Hallum78% hit rate on this stock · 9 targets measuredBuyno targetJul 6, 2026
- Charles ShiNeedham67% hit rate on this stock · 9 targets measuredBuytarget $90.00Oct 30, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Oct 30, 2026 | Unknown AnalystWedbushOct 30, 2026 | BuyReiterated | $93.00↗ | article ↗ |
| Oct 30, 2026 | Charles ShiNeedhamOct 30, 2026 | BuyMaintained | $90.00↗ | article ↗ |
| Oct 26, 2026 | Unknown AnalystWedbushOct 26, 2026 | BuyReiterated | $93.00 | |
| Jul 31, 2026 | Matt BrysonWedbushJul 31, 2026 | BuyReiterated | $93.00↗ | article ↗ |
| Jul 31, 2026 | Charles ShiNeedhamJul 31, 2026 | BuyUpgraded | $90.00↗ | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data · computed Nov 13, 2026 · 32 ratings
Frequently asked questions
Where can I trade AXTI perpetual futures?
AXT, Inc. (AXTI) perpetual futures trade on 18 crypto venues, including Binance, Deepcoin, OKX. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade AXTI around the clock?
Yes. Unlike the underlying stock, AXTI perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on AXTI perpetuals?
Right now the AXTI perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to 0.0% across 18 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the AXTI perp price compare to the AXT, Inc. stock?
The venue-median AXTI perp mark is $39.8 versus a reference stock price of $39.5, a basis of +0.7%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a AXTI perpetual future?
A AXTI perpetual is a derivative that tracks the price of AXT, Inc. with no expiry date. It lets you take long or short exposure to AXT, Inc. on crypto venues, around the clock.
What is AXTIUSDT perpetual?
AXTIUSDT is the symbol most crypto exchanges use for the AXT, Inc. perpetual settled in USDT (Tether). It tracks the AXTI share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/axti-perp"><img src="https://perpequities.com/badge/axti-perp.svg" width="240" height="64" alt="AXTI perpetuals · perpequities.com" loading="lazy"></a>